Implementing motivational interviewing to improve endocrine therapy adherence among breast cancer patients: a qualitative process evaluation of the getset pilot intervention.

IF 2.1 4区医学 Q3 ONCOLOGY Cancer Causes & Control Pub Date : 2025-07-01 Epub Date: 2025-02-20 DOI:10.1007/s10552-025-01971-y

Victoria J Dunsmore, Charlotte Ellis, Sarah Drier, Austin R Waters, Niasha Fray, Christina Stylianou, Jennifer C Spencer, Katherine E Reeder-Hayes, Stephanie B Wheeler

{"title":"Implementing motivational interviewing to improve endocrine therapy adherence among breast cancer patients: a qualitative process evaluation of the getset pilot intervention.","authors":"Victoria J Dunsmore, Charlotte Ellis, Sarah Drier, Austin R Waters, Niasha Fray, Christina Stylianou, Jennifer C Spencer, Katherine E Reeder-Hayes, Stephanie B Wheeler","doi":"10.1007/s10552-025-01971-y","DOIUrl":null,"url":null,"abstract":"Background: This study evaluates the implementation of the GETSET (Guiding Endocrine Therapy Success through Empowerment and Teamwork) pilot, a motivational interviewing (MI) intervention aimed at improving endocrine therapy (ET) adherence among patients with breast cancer.Methods: Using the Consolidated Framework for Implementation Research (CFIR), qualitative interviews were conducted with site staff (N = 2), patients (N = 4), and counselors (N = 2).Results: The thematic analysis identified facilitators such as high-quality materials, ease of scheduling sessions, and effective communication among staff. However, barriers included lack of personalization and systemic issues like understaffing.Conclusions: The study underscores the need to adapt implementation of behavioral interventions in a healthcare setting to improve ET adherence. As this was a process evaluation of a pilot study, future work should evaluate the barriers and facilitators to a larger clinical trial to identify if the same strategies should be refined.","PeriodicalId":9432,"journal":{"name":"Cancer Causes & Control","volume":" ","pages":"725-732"},"PeriodicalIF":2.1000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12103369/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Causes & Control","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10552-025-01971-y","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/20 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: This study evaluates the implementation of the GETSET (Guiding Endocrine Therapy Success through Empowerment and Teamwork) pilot, a motivational interviewing (MI) intervention aimed at improving endocrine therapy (ET) adherence among patients with breast cancer.

Methods: Using the Consolidated Framework for Implementation Research (CFIR), qualitative interviews were conducted with site staff (N = 2), patients (N = 4), and counselors (N = 2).

Results: The thematic analysis identified facilitators such as high-quality materials, ease of scheduling sessions, and effective communication among staff. However, barriers included lack of personalization and systemic issues like understaffing.

Conclusions: The study underscores the need to adapt implementation of behavioral interventions in a healthcare setting to improve ET adherence. As this was a process evaluation of a pilot study, future work should evaluate the barriers and facilitators to a larger clinical trial to identify if the same strategies should be refined.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

实施动机访谈提高乳腺癌患者内分泌治疗依从性：对getset试点干预的定性过程评估。

背景：本研究评估了GETSET（通过授权和团队合作指导内分泌治疗成功）试点的实施情况，这是一项旨在提高乳腺癌患者内分泌治疗依从性的动机性访谈（MI）干预。方法：采用综合实施研究框架（CFIR），对现场工作人员（N = 2）、患者（N = 4）和咨询师（N = 2）进行定性访谈。结果：专题分析确定了促进因素，如高质量的材料、易于安排的会议和工作人员之间的有效沟通。然而，障碍包括缺乏个性化和人员不足等系统性问题。结论：该研究强调了在医疗环境中适应行为干预措施的实施以提高ET依从性的必要性。由于这是对一项试点研究的过程评估，未来的工作应该评估进行更大规模临床试验的障碍和促进因素，以确定是否应该改进相同的策略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Cancer Causes & Control 医学-公共卫生、环境卫生与职业卫生

CiteScore

3.90

自引率

4.30%

发文量

130

审稿时长

6.6 months

期刊介绍： Cancer Causes & Control is an international refereed journal that both reports and stimulates new avenues of investigation into the causes, control, and subsequent prevention of cancer. By drawing together related information published currently in a diverse range of biological and medical journals, it has a multidisciplinary and multinational approach. The scope of the journal includes: variation in cancer distribution within and between populations; factors associated with cancer risk; preventive and therapeutic interventions on a population scale; economic, demographic, and health-policy implications of cancer; and related methodological issues. The emphasis is on speed of publication. The journal will normally publish within 30 to 60 days of acceptance of manuscripts. Cancer Causes & Control publishes Original Articles, Reviews, Commentaries, Opinions, Short Communications and Letters to the Editor which will have direct relevance to researchers and practitioners working in epidemiology, medical statistics, cancer biology, health education, medical economics and related fields. The journal also contains significant information for government agencies concerned with cancer research, control and policy.